289 related articles for article (PubMed ID: 33072095)
1. Oxidative DNA Damage Accelerates Skin Inflammation in Pristane-Induced Lupus Model.
Tumurkhuu G; Chen S; Montano EN; Ercan Laguna D; De Los Santos G; Yu JM; Lane M; Yamashita M; Markman JL; Blanco LP; Kaplan MJ; Shimada K; Crother TR; Ishimori M; Wallace DJ; Jefferies CA; Arditi M
Front Immunol; 2020; 11():554725. PubMed ID: 33072095
[TBL] [Abstract][Full Text] [Related]
2. cGAS deficiency enhances inflammasome activation in macrophages and inflammatory pathology in pristane-induced lupus.
Kumpunya S; Thim-Uam A; Thumarat C; Leelahavanichkul A; Kalpongnukul N; Chantaravisoot N; Pisitkun T; Pisitkun P
Front Immunol; 2022; 13():1010764. PubMed ID: 36591278
[TBL] [Abstract][Full Text] [Related]
3. Monocytes from Irf5-/- mice have an intrinsic defect in their response to pristane-induced lupus.
Yang L; Feng D; Bi X; Stone RC; Barnes BJ
J Immunol; 2012 Oct; 189(7):3741-50. PubMed ID: 22933628
[TBL] [Abstract][Full Text] [Related]
4. Interferon Lambda Regulates Cellular and Humoral Immunity in Pristane-Induced Lupus.
Aschman T; Schaffer S; Biniaris Georgallis SI; Triantafyllopoulou A; Staeheli P; Voll RE
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769174
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis-derived membrane vesicles drive the cGAS-STING pathway and enhance type I IFN production in systemic lupus erythematosus.
Kato Y; Park J; Takamatsu H; Konaka H; Aoki W; Aburaya S; Ueda M; Nishide M; Koyama S; Hayama Y; Kinehara Y; Hirano T; Shima Y; Narazaki M; Kumanogoh A
Ann Rheum Dis; 2018 Oct; 77(10):1507-1515. PubMed ID: 29945921
[TBL] [Abstract][Full Text] [Related]
6. CD38 promotes pristane-induced chronic inflammation and increases susceptibility to experimental lupus by an apoptosis-driven and TRPM2-dependent mechanism.
García-Rodríguez S; Rosal-Vela A; Botta D; Cumba Garcia LM; Zumaquero E; Prados-Maniviesa V; Cerezo-Wallis D; Lo Buono N; Robles-Guirado JÁ; Guerrero S; González-Paredes E; Andrés-León E; Corbí Á; Mack M; Koch-Nolte F; Merino R; Zubiaur M; Lund FE; Sancho J
Sci Rep; 2018 Feb; 8(1):3357. PubMed ID: 29463868
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of tumor necrosis factor α antagonist-induced lupus in a murine model.
Xu Y; Zhuang H; Han S; Liu C; Wang H; Mathews CE; Massini J; Yang L; Reeves WH
Arthritis Rheumatol; 2015 Jan; 67(1):225-37. PubMed ID: 25252121
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-302d targets IRF9 to regulate the IFN-induced gene expression in SLE.
Smith S; Fernando T; Wu PW; Seo J; Ní Gabhann J; Piskareva O; McCarthy E; Howard D; O'Connell P; Conway R; Gallagher P; Molloy E; Stallings RL; Kearns G; Forbess L; Ishimori M; Venuturupalli S; Wallace D; Weisman M; Jefferies CA
J Autoimmun; 2017 May; 79():105-111. PubMed ID: 28318807
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive CD11b+Ly6Chi monocytes in pristane-induced lupus mouse model.
Ma H; Wan S; Xia CQ
J Leukoc Biol; 2016 Jun; 99(6):1121-9. PubMed ID: 26657791
[TBL] [Abstract][Full Text] [Related]
10. Invariant natural killer T cells are enriched at the site of cutaneous inflammation in lupus erythematosus.
Hofmann SC; Bosma A; Bruckner-Tuderman L; Vukmanovic-Stejic M; Jury EC; Isenberg DA; Mauri C
J Dermatol Sci; 2013 Jul; 71(1):22-8. PubMed ID: 23664188
[TBL] [Abstract][Full Text] [Related]
11. In vivo study: Th1-Th17 reduction in pristane-induced systemic lupus erythematosus mice after treatment with tolerogenic Lactobacillus probiotics.
Mardani F; Mahmoudi M; Esmaeili SA; Khorasani S; Tabasi N; Rastin M
J Cell Physiol; 2018 Jan; 234(1):642-649. PubMed ID: 30078223
[TBL] [Abstract][Full Text] [Related]
12. Pleiotropic IFN-dependent and -independent effects of IRF5 on the pathogenesis of experimental lupus.
Xu Y; Lee PY; Li Y; Liu C; Zhuang H; Han S; Nacionales DC; Weinstein J; Mathews CE; Moldawer LL; Li SW; Satoh M; Yang LJ; Reeves WH
J Immunol; 2012 Apr; 188(8):4113-21. PubMed ID: 22422888
[TBL] [Abstract][Full Text] [Related]
13. A novel type I IFN-producing cell subset in murine lupus.
Lee PY; Weinstein JS; Nacionales DC; Scumpia PO; Li Y; Butfiloski E; van Rooijen N; Moldawer L; Satoh M; Reeves WH
J Immunol; 2008 Apr; 180(7):5101-8. PubMed ID: 18354236
[TBL] [Abstract][Full Text] [Related]
14. The female-biased factor VGLL3 drives cutaneous and systemic autoimmunity.
Billi AC; Gharaee-Kermani M; Fullmer J; Tsoi LC; Hill BD; Gruszka D; Ludwig J; Xing X; Estadt S; Wolf SJ; Rizvi SM; Berthier CC; Hodgin JB; Beamer MA; Sarkar MK; Liang Y; Uppala R; Shao S; Zeng C; Harms PW; Verhaegen ME; Voorhees JJ; Wen F; Ward NL; Dlugosz AA; Kahlenberg JM; Gudjonsson JE
JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996136
[TBL] [Abstract][Full Text] [Related]
15. Progranulin Mediates Proinflammatory Responses in Systemic Lupus Erythematosus: Implications for the Pathogenesis of Systemic Lupus Erythematosus.
Jing C; Zhang X; Song Z; Zheng Y; Yin Y
J Interferon Cytokine Res; 2020 Jan; 40(1):33-42. PubMed ID: 31804874
[TBL] [Abstract][Full Text] [Related]
16. Association of Abnormal Elevations in IFIT3 With Overactive Cyclic GMP-AMP Synthase/Stimulator of Interferon Genes Signaling in Human Systemic Lupus Erythematosus Monocytes.
Wang J; Dai M; Cui Y; Hou G; Deng J; Gao X; Liao Z; Liu Y; Meng Y; Wu L; Yao C; Wang Y; Qian J; Guo Q; Ding H; Qu B; Shen N
Arthritis Rheumatol; 2018 Dec; 70(12):2036-2045. PubMed ID: 29806091
[TBL] [Abstract][Full Text] [Related]
17. Type 1 Interferon Gene Signature Promotes RBC Alloimmunization in a Lupus Mouse Model.
Lee JY; Madany E; El Kadi N; Pandya S; Ng K; Yamashita M; Jefferies CA; Gibb DR
Front Immunol; 2020; 11():584254. PubMed ID: 33101313
[TBL] [Abstract][Full Text] [Related]
18. Expression of Cyclic GMP-AMP Synthase in Patients With Systemic Lupus Erythematosus.
An J; Durcan L; Karr RM; Briggs TA; Rice GI; Teal TH; Woodward JJ; Elkon KB
Arthritis Rheumatol; 2017 Apr; 69(4):800-807. PubMed ID: 27863149
[TBL] [Abstract][Full Text] [Related]
19. Neutrophils Contribute to ER Stress in Lung Epithelial Cells in the Pristane-Induced Diffuse Alveolar Hemorrhage Mouse Model.
Tumurkhuu G; Laguna DE; Moore RE; Contreras J; Santos GL; Akaveka L; Montano EN; Wang Y; Ishimori M; Venuturupalli S; Forbess LJ; Stripp BR; Wallace DJ; Jefferies CA
Front Immunol; 2022; 13():790043. PubMed ID: 35185885
[TBL] [Abstract][Full Text] [Related]
20. Familial chilblain lupus due to a gain-of-function mutation in STING.
König N; Fiehn C; Wolf C; Schuster M; Cura Costa E; Tüngler V; Alvarez HA; Chara O; Engel K; Goldbach-Mansky R; Günther C; Lee-Kirsch MA
Ann Rheum Dis; 2017 Feb; 76(2):468-472. PubMed ID: 27566796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
